DENVER--(BUSINESS WIRE)--Jul. 8, 2013--
DaVita HealthCare Partners Inc. (NYSE:DVA) announced today that Garry E.
Menzel, Ph.D., is to join the company in mid-September and become its
Chief Financial Officer. He will start as Senior Vice President,
Finance, and begin officially serving as the Chief Financial Officer the
day after the company files its Quarterly Report on Form 10-Q for the
quarter ended September 30, 2013.
Menzel, 48, most recently held the positions of Chief Operating Officer
and Chief Financial Officer at Regulus Therapeutics Inc., a
publicly-traded biopharmaceutical company (NASDAQ: RGLS). Prior to
joining Regulus in 2008, he had a 14-year career on Wall Street where he
was a Managing Director and Global Head of Life Sciences for Credit
Suisse and a Managing Director and Global Head of Biotechnology for
Goldman Sachs. Menzel also spent several years as a strategy consultant
for Bain & Company.
Menzel earned a B.Sc. with honors in biochemistry from the Imperial
College of Science & Technology in London, England, a Ph.D. in molecular
biology from the University of Cambridge, England, and a Masters in
Business Administration from the Stanford Graduate School of Business.
Jim Hilger, who has served as Interim Chief Financial Officer since
2012, and Acting Chief Financial Officer from 2007 to 2008, will
continue in his role as the company’s Chief Accounting Officer, a
position he has held since 2010.
“We believe we have found an executive with a versatile set of skills,
from advanced finance to demonstrated strategic capabilities,” said Kent
Thiry, Co-Chairman and Chief Executive Officer of DaVita HealthCare
Partners. “Given the nimbleness that is required for all healthcare
providers we are excited to have Garry join our leadership team.”
About DaVita HealthCare Partners
DaVita HealthCare Partners, a Fortune 500® company, is the parent
company of DaVita and HealthCare Partners. DaVita is a leading provider
of kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease. As of
March 31, 2013, DaVita operated or provided administrative services at
1,991 outpatient dialysis centers in the United States serving
approximately 156,000 patients, and at 41 centers in eight countries
outside of the United States. HealthCare Partners manages and operates
medical groups and affiliated physician networks in California, Nevada,
Florida and New Mexico in its pursuit to deliver excellent-quality
health care in a dignified and compassionate manner. As of March 31,
2013, HealthCare Partners provided integrated care management for
approximately 742,000 managed care patients. For more information,
please visit DaVitaHealthCarePartners.com.
Source: DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
Investor Contact Information:
Skip Thurman, 303-876-6610